Swiss preventive health startup Ahead Health raises $10M for Germany and Netherlands launch

Ahead Health has raised $10 million in funding, with 3VC and RTP Global leading the round, to expand into Germany and the Netherlands.
This new funding comes seven months after a $6 million seed round, as competitors such as Neko Health invest heavily in preventive care, including a $700 million commitment.
People in Munich can now book preventive check-ups, and the Netherlands has already started a waitlist ahead of its August launch.

Nick Lenten discovered the cause of his long-term lower back pain through an MRI scan at his own company. This experience is now central to Ahead Health‘s message: find what regular annual check-ups might miss. The Zurich-based company has raised $10 million in a round led by 3VC and RTP Global to expand into Germany and the Netherlands.

“We built Ahead in Switzerland to prove that prevention can be rigorous, fast and useful, and it works. Starting today, people in Munich can book a preventive check-up, and the Netherlands waitlist is now open. We’re assembling a leading team in European prevention, and we’re only getting started,” says Lenten, founder and chief executive of Ahead Health.

Rapid expansion from seed funding in seven months

Lenten founded Ahead Health in 2024 after spending 16 years at Coolblue, where he was the first employee and later served as chief technology officer and chief marketing officer. He also held product leadership roles at Google and was chief customer officer at Suitsupply. Before expanding, Ahead Health built a network of more than 20 partner centres across Switzerland.

RTP Global led Ahead Health’s $6 million seed round in January, which helped develop the platform and start its European growth. Seven months later, RTP Global invested again, this time with 3VC, a Vienna-based fund focused on the DACH region. In total, the company has raised about $16 million in two rounds within a year.

Peter Lasinger, partner at 3VC, stated that the fund supports only a select number of teams each year, focusing on founders addressing critical global challenges.

“Ahead Health stands out because they combine a deeply mission-driven culture with absolute rigour and deep technical excellence. They’re not just building a platform, they are transforming healthcare from the ground up. We’re incredibly proud to support this world-class team as they expand into Germany and the Netherlands,” he notes

What the platform does

The startup integrates blood panels, whole-body MRI, and an AI platform that consolidates a member’s medical history into a single, doctor-reviewed check-up. Instead of providing a one-time assessment, it monitors each member’s results over time to identify significant changes early.

The rollout in Germany and the Netherlands begins with blood tests assessing metabolic health, inflammatory markers, organ function, and cardiovascular risk, with imaging capabilities to be introduced later.

For example, someone without any clear symptoms might get a blood test that finds an early sign of inflammation. This could lead to a doctor-reviewed action plan months before a regular annual check-up would notice anything.

Anna Erat, chief medical officer at Ahead Health, notes that most healthcare today only reacts to problems. “The real opportunity is to detect the earliest signals that may lead to disease or suboptimal health, and empower individuals to optimise their long-term health and performance through clear, personalised actions, supported by the best technologies available today,” she says.

Instead of opening its own clinics, Ahead Health works with existing radiology centres and doctors in each new market. This cost-effective strategy for entering Germany and the Netherlands helps the company avoid the construction costs incurred by competitors such as Neko Health.

The sector has seen much larger investments recently. Sweden’s Neko Health, co-founded by Spotify’s Daniel Ek, closed a $700 million Series C round in July, boosting its valuation from $1.8 billion to nearly $7 billion in just 18 months. Other preventive health startups include Paris-based Lucis, which raised $20 million in a Series A; UK-based Emerald, which launched with £625,000; US whole-body MRI provider Prenuvo, which has raised $192 million on about $250 million in annual revenue; blood-biomarker platform Function Health, which reached a $2.5 billion valuation after raising $298 million; and lab-partnered competitor Superpower, which raised $30 million in its own Series A.

Unlike rivals, Ahead Health offers a combined, doctor-reviewed platform that uses existing infrastructure. The longevity and preventive health clinic market was valued at $6.02 billion in 2026 and is expected to reach $9.55 billion by 2030, growing at a 12.2% annual rate. This growth should support several different approaches to preventive care.

Neko’s rise from $1.8 billion to nearly $7 billion in just 18 months shows how much investment is flowing into this sector. The bigger question for Ahead Health is whether its lean, partnership-based model can grow quickly enough before a fully integrated competitor enters the same markets.